Regulation of ovarian cancer cell viability and sensitivity to cisplatin by progesterone receptor membrane component-1

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 5, 2008, Pages 1592-1599

  Peluso, John J ^a   Liu, Xiufang ^a   Saunders, M Melinda ^a   Claffey, Kevin P ^a   Phoenix, Kathryn ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; PROGESTERONE RECEPTOR; PROGESTERONE RECEPTOR MEMBRANE COMPONENT 1; RNA;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER STAGING; CELL VIABILITY; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; OVARY CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 43249120558     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-2771     Document Type: Article

References (47)

1. M Salzberg B Thurlimann H Bonnefois D Fink C Rochlitz R von Moos H Senn Current concepts of treatment strategies in advanced or recurrent ovarian cancer Oncology 68 2005 293 298
2. P Lindgren T Backstrom CG Mahlck M Ridderheim S Cajander Steroid receptors and hormones in relation to cell proliferation and apoptosis in poorly differentiated epithelial ovarian tumors Int J Oncol 19 2001 31 38
3. MN Barnes WD Berry JM Straughn TO Kirby CA Leath WK Huh WE Grizzle EE Partridge A pilot study of ovarian cancer chemoprevention using medroxyprogesterone acetate in an avian model of spontaneous ovarian carcinogenesis Gynecol Oncol 87 2002 57 63
4. SM Ho Estrogen, progesterone and epithelial ovarian cancer Reprod Biol Endocrinol 1 2003 73
5. A Lukanova R Kaaks Endogenous hormones and ovarian cancer: epidemiology and current hypotheses Cancer Epidemiol Biomarkers Prev 14 2005 98 107
6. JL Juengel GD Niswender Molecular regulation of luteal progesterone synthesis in domestic ruminants J Reprod Fertil Suppl 54 1999 193 205
7. MT Rae SG Hillier Steroid signalling in the ovarian surface epithelium Trends Endocrinol Metab 16 2005 327 333
8. MR Cameron MR Caudle Sullivan WR Jr JJ Peluso J Wimalasena The steroidogenic and morphological effects of paclitaxel on cultured ovarian cancer cells Oncol Res 7 1995 145 156
9. S Yu M Lee S Shin J Park Apoptosis induced by progesterone in human ovarian cancer cell line SNU-840 J Cell Biochem 82 2001 445 451
10. GC Rodriguez DK Walmer M Cline H Krigman BA Lessey RS Whitaker R Dodge CL Hughes Effect of progestin on the ovarian epithelium of macaques: cancer prevention through apoptosis? J Soc Gynecol Investig 5 1998 271 276
11. AC McDonnel EA Van Kirk DD Isaak WJ Murdoch Effects of progesterone on ovarian tumorigenesis in xenografted mice Cancer Lett 221 2005 49 53
12. BJ Slotman JJ Nauta BR Rao Survival of patients with ovarian cancer. Apart from stage and grade, tumor progesterone receptor content is a prognostic indicator Cancer 66 1990 740 744
13. RE Hempling MS Piver GH Eltabbakh FO Recio Progesterone receptor status is a significant prognostic variable of progression-free survival in advanced epithelial ovarian cancer Am J Clin Oncol 21 1998 447 451
14. K Munstedt J Steen AG Knauf T Buch R von Georgi FE Franke Steroid hormone receptors and long term survival in invasive ovarian cancer Cancer 89 2000 1783 1791
15. H Gabra L Taylor BB Cohen A Lessels DM Eccles RC Leonard JF Smyth CM Steel Chromosome 11 allele imbalance and clinicopathological correlates in ovarian tumours Br J Cancer 72 1995 367 375
16. H Gabra SP Langdon JE Watson RA Hawkins BB Cohen L Taylor J Mackay CM Steel RC Leonard JF Smyth Loss of heterozygosity at 11q22 correlates with low progesterone receptor content in epithelial ovarian cancer Clin Cancer Res 1 1995 945 953
17. M Davis A Hitchcock WD Foulkes IG Campbell Refinement of two chromosome 11q regions of loss of heterozygosity in ovarian cancer Cancer Res 56 1996 741 744
18. X Chen Y Feng Effect of progesterone combined with chemotherapy on epithelial ovarian cancer Chin Med J (Engl) 116 2003 388 391
19. JJ Peluso A Pappalardo R Losel M Wehling Progesterone membrane receptor component 1 expression in the immature rat ovary and its role in mediating progesterone's antiapoptotic action Endocrinology 147 2006 3133 3140
20. JJ Peluso A Pappalardo R Losel M Wehling Expression and function of PAIRBP1 within gonadotropin-primed immature rat ovaries: PAIRBP1 regulation of granulosa and luteal cell viability Biol Reprod 73 2005 261 270
21. G Crudden RE Chitti RJ Craven Hpr6 (heme-1 domain protein) regulates the susceptibility of cancer cells to chemotherapeutic drugs J Pharmacol Exp Ther 316 2006 448 455
22. G Crudden R Loesel RJ Craven Overexpression of the cytochrome p450 activator hpr6 (heme-1 domain protein/human progesterone receptor) in tumors Tumour Biol 26 2005 142 146
23. KY Kim KC Choi SH Park CS Chou N Auersperg PC Leung Type II gonadotropin-releasing hormone stimulates p38 mitogen-activated protein kinase and apoptosis in ovarian cancer cells J Clin Endocrinol Metab 89 2004 3020 3026
24. KJ Livak TD Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2[-ΔΔC(T)] method Methods 25 2001 402 408
25. L Engmann R Losel M Wehling JJ Peluso Progesterone regulation of human granulosa/luteal cell viability by an RU486-independent mechanism J Clin Endocrinol Metab 91 2006 4962 4968
26. R Losel S Breiter M Seyfert M Wehling E Falkenstein Classic and non-classic progesterone receptors are both expressed in human spermatozoa Horm Metab Res 37 2005 10 14
27. R Losel A Dorn-Beineke E Falkenstein M Wehling M Feuring Porcine spermatozoa contain more than one membrane progesterone receptor Int J Biochem Cell Biol 36 2004 1532 1541
28. JJ Peluso J Romak X Liu Progesterone receptor membrane component-1 (PGRMC1) is the mediator of progesterone's anti-apoptotic action in spontaneously immortalized granulosa cells as revealed by PGRMC1 siRNA treatment and functional analysis of PGRMC1 mutations Endocrinology 149 2008 534 543
29. E Falkenstein C Eisen K Schmieding M Krautkramer C Stein R Losel M Wehling Chemical modification and structural analysis of the progesterone membrane binding protein from porcine liver membranes Mol Cell Biochem 218 2001 71 79
30. CJ Krebs ED Jarvis J Chan JP Lydon S Ogawa DW Pfaff A membrane-associated progesterone-binding protein, 25-Dx, is regulated by progesterone in brain regions involved in female reproductive behaviors Proc Natl Acad Sci USA 97 2000 12816 12821
31. S Bernauer M Wehling D Gerdes E Falkenstein The human membrane progesterone receptor gene: genomic structure and promoter analysis DNA Seq 12 2001 13 25
32. M Beato G Chalepakis M Schauer EP Slater DNA regulatory elements for steroid hormones J Steroid Biochem 32 1989 737 747
33. SA Beausoleil M Jedrychowski D Schwartz JE Elias J Villen J Li MA Cohn LC Cantley SP Gygi Large-scale characterization of HeLa cell nuclear phosphoproteins Proc Natl Acad Sci USA 101 2004 12130 12135
34. R Fauvet C Dufournet Etienne C Poncelet AF Bringuier G Feldmann E Darai Effects of progesterone and anti-progestin (mifepristone) treatment on proliferation and apoptosis of the human ovarian cancer cell line, OVCAR-3 Oncol Rep 15 2006 743 748
35. M Keith Bechtel B Bonavida Inhibitory effects of 17β-estradiol and progesterone on ovarian carcinoma cell proliferation: a potential role for inducible nitric oxide synthase Gynecol Oncol 82 2001 127 138
36. H Seeger D Wallwiener AO Mueck Is there a protective role of progestogens on the proliferation of human ovarian cancer cells in the presence of growth factors? Eur J Gynaecol Oncol 27 2006 139 141
37. V Syed G Ulinski SC Mok GK Yiu SM Ho Expression of gonadotropin receptor and growth responses to key reproductive hormones in normal and malignant human ovarian surface epithelial cells Cancer Res 61 2001 6768 6776
38. RL Stouffer Progesterone as a mediator of gonadotrophin action in the corpus luteum: beyond steroidogenesis Hum Reprod Update 9 2003 99 117
39. CA Lange Making sense of cross-talk between steroid hormone receptors and intracellular signaling pathways: who will have the last word? Mol Endocrinol 18 2004 269 278
40. V Cepeda MA Fuertes J Castilla C Alonso C Quevedo JM Perez Biochemical mechanisms of cisplatin cytotoxicity Anticancer Agents Med Chem 7 2007 3 18
41. V Horvath K Soucek L Svihalkova-Sindlerova J Vondracek O Blanarova J Hofmanova P Sova A Kozubik Different cell cycle modulation following treatment of human ovarian carcinoma cells with a new platinum(IV) complex vs cisplatin Invest New Drugs 25 2007 435 443
42. J Akahira T Suzuki K Ito C Kaneko AD Darnel T Moriya K Okamura N Yaegashi H Sasano Differential expression of progesterone receptor isoforms A and B in the normal ovary, and in benign, borderline, and malignant ovarian tumors Jpn J Cancer Res 93 2002 807 815
43. ME Crowther KE Britton M Granowska JH Shepherd Monoclonal antibodies and their usefulness in epithelial ovarian cancer. A review Br J Obstet Gynaecol 96 1989 516 521
44. Z Racz P Hamar Can siRNA technology provide the tools for gene therapy of the future? Curr Med Chem 13 2006 2299 2307
45. KV Morris Therapeutic potential of siRNA-mediated transcriptional gene silencing Biotechniques Suppl 2006 7 13
46. FY Xie MC Woodle PY Lu Harnessing in vivo siRNA delivery for drug discovery and therapeutic development Drug Discov Today 11 2006 67 73
47. JJ Peluso Non-genomic actions of progesterone in the normal and neoplastic mammalian ovary Semin Reprod Med 25 2007 198 207